Life Science

Gilead Sciences Inc (GILD)

December 8, 2017

Low HCV product sales is a concern

  • Gilead Sciences Inc (GILD)

  • Life Science

    Novartis AG (NVS)

    December 4, 2017

    Despite of 2% Y/Y growth, NVS saw volume growth in Q3FY17

  • Novartis AG (NVS)

  • Life Science

    Thermo Fisher Scientific (TMO)

    November 29, 2017

    Patheon acquisition to boost Laboratory Products revenues

  • Thermo Fisher Scientific (TMO)

  • Life Science

    Amgen, Inc. (AMGN)

    November 24, 2017

    Biosimilars, an imperative growth driver for AMGN

  • Amgen, Inc. (AMGN)

  • Life Science

    Biogen Inc (BIIB)

    November 21, 2017

    Biogen reported its Q3FY17 results with strong double-digit growth in its bottom-line and EPS. Biogen continued the launch of SPINRAZA in U.S. Biosimilar reveneus surged as BENEPALI sales grew strong...

  • Biogen Inc (BIIB)

  • Life Science

    Abbott Laboratories (ABT)

    November 8, 2017

    Acquisition of Alere and launch of Alinity Systems to boost Diagnostic segment growth

  • Abbott Laboratories (ABT)

  • Downloaded Product

    Pharma Industry CrispIdea

    October 18, 2017

  • Pharma Industry CrispIdea

  • Life Science

    Valeant Pharmaceuticals Intl, Inc. (VRX)

    September 27, 2017

    Plans to repay debt by taking path of divestures

  • Valeant Pharmaceuticals Intl, Inc. (VRX)

  • Life Science

    Sanofi S.A. (SNY)

    September 11, 2017

    8.7% growth in 1HFY17 and Protein Science acquisition shows positive growth

  • Sanofi S.A. (SNY)